Bridgebio Pharma Inc. (bbio 2.5 03/15/27)
13F holders, Q2 2024 (June 30)3holders −1
2new positions
3sold out
$1.01avg. 13F price*
At the end of Q2 2024, 3 institutions reported holding Bridgebio Pharma Inc. (bbio 2.5 03/15/27) in their 13F filings, down 1 from Q1 2024. 2 opened new positions and 3 sold out. The largest holders were New York State Common Retirement Fund ($3.0M), Bank of New York Mellon Corp ($495K) and Choreo, LLC ($18K).
- Company
- Bridgebio Pharma Inc. (bbio 2.5 03/15/27)
- CUSIP
- 10806XAB8
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $3.0M |
| Exits | 3 | $6.0M |
All 13F filers, Q1 2024 → Q2 2024: 3,003,000 shares bought and 5,585,000 shares sold, net −2,582,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| New York State Common Retirement Fund | 0.00% | New | 2,985,000 | $3.0M |
| Bank of New York Mellon Corp | 0.00% | No change | 500,000 | $495K |
| Choreo, LLC | 0.00% | New | 18,000 | $18K |
"% of holder's portfolio" is BRIDGEBIO PHARMA INC (BBIO 2.5 03/15/27)'s weight in each manager's 13F, not the share of Bridgebio Pharma Inc. (bbio 2.5 03/15/27) the manager owns.